Eric Lefkofsky is an American entrepreneur with a proven track record of transforming business ideas into lucrative businesses. He is widely known as the chief executive officer and co-founder of Tempus, a technology company behind the creation of an operating system to fight cancer. Aside from Tempus, Eric is behind the formation of other companies like Uptake, Groupon, Lightbank, and MediaBank.
Lefkofsky’s Education Background
Lefkofsky comes from a family that boasts of an excellent academic background. When growing up, his father was a structural engineer while his mother was a school teacher. Eric has a brother who currently serves as a practicing attorney in Michigan. Lefkofsky Twitter .
Lefkofsky graduated in 1987 from Southfield-Lathrup High School. Later in 1991, he graduated from the University of Michigan with honors. His academic journey did not stop there, as he went ahead to receive a Juris Doctor at the University of Michigan Law School in 1993.
Philanthropy and Community Interests of Lefkofsky
Lefkofsky and his wife, Elizabeth, are acknowledged for founding a charitable trust dubbed as the Lefkofsky Foundation. They came up with the foundation in a bid to support scientific, educational and charitable causes and organizations all over the world.
The Lefkofsky Foundation also focuses on children. To date, the foundation prides itself for funding over 50 organizations around the world. Both Lefkofsky and his wife are members of The Giving Pledge. Additionally, he serves on various boards including The Art Institute of Chicago, Children’s Memorial Hospital based in Chicago, World Business Chicago and The Museum of Science and Industry.
Tempus prides itself as the technology company behind the creation of an operating system specifically for battling cancer. Since its inception in 2015, Tempus has enabled physicians to provide personalized cancer care via its machine learning and interactive analytical platform. Tempus also has a reputation for providing outstanding genomic sequencing services, as well as therapeutic and molecular data analysis. These services are meant to help physicians to formulate data-driven and real-time decisions.
http://lefkofskyfoundation.com for more.